Aeterna Zentaris Abstract Accepted for Presentation at 13th

– Company to present regarding AIM Biologicals as a potential therapeutic treatment option for neuromyelitis optica spectrum disorder ("NMOSD"), an orphan...

Related Keywords

Greece ,Athens ,Attikír ,Canada ,Toronto ,Ontario ,Ukraine ,Canadian ,Lou Gehrig ,Jenene Thomas ,Klaus Paulini ,Valentin Bruttel ,School Of Medicine ,Department Of Obstetrics ,Linkedin ,Aeterna Zentaris ,Company On Twitter ,European Commission ,Megaron Athens International Conference Centre ,Nasdaq ,University Of Wuerzburg The ,Aeterna Zentaris Inc ,Toronto Stock Exchange ,Facebook ,International Congress On Autoimmunity ,Novo Nordisk ,Autoimmunity Modifying Biologicals ,International Congress ,Senior Researcher ,Parallel Session ,Nervous System ,Chief Executive Officer ,Neuromyelitis Optica Spectrum Disorder ,Litigation Reform Act ,Novo Amended License Agreement ,Annual Report ,Nasdaq Aezs ,Nmosd ,Orphan Indication ,Medical Need ,Sx Aezs ,Iopharmaceutical Company ,